Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Benchmark Initiates Coverage On Landstar System with Hold Rating

Benchmark analyst Christopher Kuhn initiates coverage on Landstar System (NASDAQ:LSTR) with a Hold rating.

byBenzinga Newsdesk

August 31, 2022

1 minute read

Benchmark analyst Christopher Kuhn initiates coverage on Landstar System (NASDAQ:LSTR) with a Hold rating.

Atlantic Equities Downgrades Robinhood Markets to Underweight, Announces $5 Price Target

By Benzinga Newsdesk

Today, 8:02 AM

Atlantic Equities analyst John Heagerty downgrades Robinhood Markets (NASDAQ:HOOD) from Neutral to Underweight and announces $5 price target.

HOOD

Stifel Initiates Coverage On HilleVax with Buy Rating, Announces Price Target of $34

By Benzinga Newsdesk

Today, 8:02 AM

Stifel analyst Stephen Willey initiates coverage on HilleVax (NASDAQ:HLVX) with a Buy rating and announces Price Target of $34.

HLVX

Barclays Downgrades ZIM Integrated Shipping to Underweight, Lowers Price Target to $15

By Benzinga Newsdesk

Today, 8:02 AM

Barclays analyst Alexia Dogani downgrades ZIM Integrated Shipping (NYSE:ZIM) from Equal-Weight to Underweight and lowers the price target from $26.5 to $15.

ZIM

B. Riley Securities Maintains Buy on Allogene Therapeutics, Lowers Price Target to $18

By Benzinga Newsdesk

Today, 8:02 AM

B. Riley Securities analyst Kalpit Patel maintains Allogene Therapeutics (NASDAQ:ALLO) with a Buy and lowers the price target from $21 to $18.

ALLO

Benchmark Initiates Coverage On Landstar System with Hold Rating

Related Posts

Atlantic Equities Downgrades Robinhood Markets to Underweight, Announces $5 Price Target

Stifel Initiates Coverage On HilleVax with Buy Rating, Announces Price Target of $34

Barclays Downgrades ZIM Integrated Shipping to Underweight, Lowers Price Target to $15

B. Riley Securities Maintains Buy on Allogene Therapeutics, Lowers Price Target to $18